Skip to main content
. 2021 Nov 25;375:e066045. doi: 10.1136/bmj-2021-066045

Table 2.

Quality of evidence and strength of recommendations in consensus and evidence based recommendations in American Society of Clinical Oncology guidelines

Strength of recommendations Quality of evidence
High Moderate Low
Consensus approach (n=358):
 Strong 4 (100) 18 (29) 92 (32)
 Moderate 0 37 (60) 141(48)
 Weak 0 7 (11) 59 (20)
 Totals (%) 4 (100) 62 (100) 292 (100)
Evidence approach (n=736):
 Strong 225 (89) 162 (44) 30 (27)
 Moderate 26 (10) 189 (51) 39 (35)
 Weak 3 (1) 19 (5) 43 (38)
 Totals (%) 254 (100) 370 (100) 112 (100)